{
  "attach_pages": "4",
  "attach_size": "394",
  "attach_type": "0",
  "attach_url": "https://pdf.dfcfw.com/pdf/H3_AP201904221321142362_1.pdf?1555924709000.pdf",
  "company_code": "80000155",
  "eitime": "2019-04-22 09:11:44",
  "extend": {},
  "info_code": "AP201904221321142362",
  "language": "0",
  "notice_date": "2019-04-22 00:00:00",
  "notice_title": "18Q4业绩超预期 持续推进在研管线布局",
  "page_size": 1,
  "page_size_ch": 0,
  "page_size_cht": 0,
  "page_size_en": 0,
  "rating": "AA",
  "researcher": "金鑫",
  "security": [
    {
      "market_uni": "0",
      "publish_relation": [
        {
          "originalCode": "465",
          "publishName": "化学制药"
        }
      ],
      "short_name": "华东医药",
      "short_name_ch": "华东医药",
      "short_name_cht": "華東醫藥",
      "short_name_en": "HD MEDICINE",
      "stock": "000963"
    }
  ],
  "short_name": "华东医药",
  "source_sample_name": "上海证券",
  "star": "3"
}